Molecular Parasitology Funding

Although we were delighted to see attention being paid to molecular parasitology (K.Y. Kreeger, The Scientist, April 29, 1996, page 13), we were surprised by an omission. In addition to the three other organizations mentioned as being involved in this field, the Burroughs Wellcome Fund (BWF) has invested more than $11 million in parasitology research over the past 14 years. The fund began its molecular parasitology award program to encourage the application of fundamental research to the study

Written byMartha Peck
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Although we were delighted to see attention being paid to molecular parasitology (K.Y. Kreeger, The Scientist, April 29, 1996, page 13), we were surprised by an omission. In addition to the three other organizations mentioned as being involved in this field, the Burroughs Wellcome Fund (BWF) has invested more than $11 million in parasitology research over the past 14 years.

The fund began its molecular parasitology award program to encourage the application of fundamental research to the study of parasitic diseases. Twenty-three United States scientists have received Scholar Awards, which provide $400,000 each over five years. Twenty-one individuals have received New Investigator awards of $150,000 each over three years. Many of the leading researchers in parasitology, including several of those mentioned in the article, are BWF awardees.

This year, recognizing the worldwide importance of malaria and the need to foster basic research on malaria pathogenesis, the fund launched a new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies